Supporting the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month".
The resolution emphasizes that DVT and PE are prevalent in the United States, affecting an estimated 900,000 individuals annually and leading to approximately 100,000 deaths each year. Furthermore, it points out that these conditions lead to significant medical costs, contributing over $10 billion in incremental expenses. Establishing March as DVT and PE Awareness Month is intended to inspire proactive measures in healthcare to reduce these statistics, ultimately leading to better outcomes for at-risk populations.
House Resolution 214 (HR214) aims to support the goals and ideals of 'Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Awareness Month'. This resolution highlights the significance of raising awareness about DVT and PE, conditions that pose serious health risks and contribute significantly to hospital deaths in the United States. It acknowledges the need for public education to mitigate the risks associated with DVT and PE, which are often preventable.
While HR214 does not propose specific legislative changes, its passage reflects a growing understanding of the importance of preventive health measures and public education. Notable points of contention around awareness campaigns typically involve debates on funding, prioritization of health issues, and potential governmental roles in healthcare education. Advocates for public health initiatives argue that raising awareness can lead to significant reductions in healthcare costs and improvements in patient outcomes, while critics may concern about the effectiveness and efficiency of such awareness campaigns.